GO:0045807 positive regulation of endocytosis: Signaling Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045807 (positive regulation of endocytosis) describes any process that activates or increases the frequency, rate or extent of endocytosis, the vesicular uptake of extracellular material and plasma membrane components.
• Endocytosis is not a housekeeping constant; it is context-dependently tuned by cargo, receptors, signaling cues and cell state, which is why positive regulators are central to cell biology.
• Key positive regulators include Rab5 and its effector complex FERRY, which link early endosomes to mRNA localization and endosomal function.
• Receptor trafficking is a major node of positive regulation: TGF-beta signaling is controlled by endocytic sorting, and transferrin receptor trafficking is regulated by optineurin and its disease mutants.
• In cancer, increasing endocytosis of antibody-drug conjugates such as T-DM1 can enhance antitumor activity, as shown for pyrotinib in HER2-positive breast cancer.
• CD44-mediated iron endocytosis links uptake to epigenetic plasticity, showing that positive regulation of endocytosis can reshape gene expression programs.
Description
Endocytosis is the process by which cells internalize extracellular molecules, membrane proteins and lipids through vesicular carriers, and it is fundamental to nutrient uptake, receptor signaling, cell adhesion and communication. The Gene Ontology term GO:0045807, positive regulation of endocytosis, captures any process that activates or increases the frequency, rate or extent of this uptake, distinguishing it from the constitutive baseline of membrane turnover. Because endocytic flux determines how long a receptor signals, where a ligand is delivered and how a cell senses its environment, positive regulators act as context-dependent control points in physiology and disease. Researchers study GO:0045807 to understand how cells accelerate uptake in response to cues such as growth factors, pathogens, iron-loaded ligands or therapeutic antibodies, and to identify druggable nodes that can be tuned up or down. The term is also practically important because endocytosis is a shared step in many signaling pathways: TGF-beta receptors are sorted through endocytic compartments, transferrin receptor recycling depends on adaptors such as optineurin, and early endosome identity is maintained by Rab5 and its effectors. In translational settings, positive regulation of endocytosis can be the difference between an effective and ineffective antibody-drug conjugate, as demonstrated for T-DM1 in HER2-positive cancer cells. This article summarizes the definition, mechanism, key genes, disease links and experimental methods for GO:0045807, with all claims anchored to published literature.
positive regulation of endocytosis At A Glance
| GO ID | GO:0045807 |
|---|---|
| GO term | positive regulation of endocytosis |
| Ontology | biological_process |
| Definition | Any process that activates or increases the frequency, rate or extent of endocytosis. |
| Synonyms | activation of endocytosis; stimulation of endocytosis; up regulation of endocytosis; up-regulation of endocytosis; upregulation of endocytosis |
| Major function | Increases the rate or extent of vesicular uptake of extracellular material and plasma membrane components, thereby tuning nutrient acquisition, receptor signaling and cell communication. |
| Representative regulators | Rab5 and its effector FERRY; optineurin in transferrin receptor trafficking; CD44 in iron endocytosis. |
| Disease relevance | Cancer drug uptake, atherosclerosis, and neurodegenerative mechanisms involving endosomal trafficking. |
| Research methods | Live-cell imaging of uptake, fluorescent cargo assays, proteomics of endosomes, CRISPR perturbation and transcriptomics. |
What Is GO:0045807?
GO:0045807, positive regulation of endocytosis, is a biological process term defined as any process that activates or increases the frequency, rate or extent of endocytosis. In practice, this means a gene product or signal that raises the amount of membrane internalized, the number of endocytic events, or the efficiency of cargo capture and vesicle formation, relative to a baseline state. It is the positive counterpart of negative regulation of endocytosis and is distinct from endocytosis itself, because it describes the regulatory input rather than the uptake machinery per se.
Why Is positive regulation of endocytosis Important in Cell Biology?
Positive regulation of endocytosis is important because it sets the gain on how cells sample their environment and how long signaling receptors remain active. Endocytosis is now understood as a context-dependent regulator of individual and collective cell properties, meaning that changing uptake rates can alter polarity, migration, signaling output and cell fate. This has direct consequences for how cells respond to nutrients, growth factors and drugs, and it explains why endocytic regulators appear in cancer, metabolic and neurological disease mechanisms.
• Controls the duration and intensity of receptor signaling by determining whether receptors are recycled or degraded.
• Regulates nutrient uptake, including iron delivery via CD44-mediated endocytosis, which can influence epigenetic state.
• Modulates cell-cell communication and collective cell behaviors such as migration and invasion.
• Determines the efficacy of antibody-drug conjugates by controlling how much drug enters tumor cells.
• Links to vascular disease through endocytic regulation of smooth muscle cell transdifferentiation and lipid accumulation.
• Is implicated in neurodegeneration through disease-associated mutations in trafficking proteins such as optineurin.
• Provides a druggable axis: increasing endocytosis can sensitize tumors to targeted therapies.
• Serves as a mechanistic explanation for how extracellular cues are converted into transcriptional and epigenetic changes.
• Is essential for immune surveillance and pathogen entry, making it a host-pathogen interface.
• Offers a rich source of CRISPR targets for functional genomics of uptake and trafficking.
What Happens During positive regulation of endocytosis?
Initiation and cargo recognition at the plasma membrane
In simple terms: The cell first decides what to take in by tagging cargo at the surface.
Positive regulation begins with signals that increase the recruitment of cargo and coat components to the plasma membrane. Endocytosis is context-dependent, so the same cell can switch between low and high uptake states depending on ligand availability, receptor activation and membrane composition. Cargo such as transferrin-bound iron or antibody-drug conjugates must be recognized and concentrated before vesicle formation, and regulators that increase this recognition step effectively raise endocytic rate.
Vesicle formation and scission
In simple terms: The membrane bends inward and pinches off to make a vesicle.
Once cargo is selected, positive regulators promote the assembly of the machinery that bends the membrane and drives scission. This step determines the frequency of endocytic events, and its upregulation increases the number of vesicles formed per unit time. The efficiency of this step is critical for drug delivery, because antibody-drug conjugates such as T-DM1 depend on vesicle formation for cellular entry.
Early endosome identity and Rab5-dependent fusion
In simple terms: New vesicles fuse with early endosomes, the sorting hub of the cell.
After scission, vesicles fuse with early endosomes, a step governed by Rab5 and its effectors. The Rab5 effector FERRY links early endosomes with mRNA localization, showing that positive regulation of endocytosis is coupled to RNA handling and endosomal function. This fusion step is a major control point because it determines whether internalized cargo is sorted for recycling or degradation.
Sorting, recycling and degradation
In simple terms: The cell decides whether to send cargo back to the surface or destroy it.
Positive regulation of endocytosis also influences downstream sorting. Transferrin receptor trafficking is regulated by optineurin and its disease-associated mutants, which affects recycling versus degradation. Similarly, TGF-beta signaling is controlled by endocytic sorting, so increasing endocytosis can either enhance or terminate signaling depending on the sorting route. In cancer cells, the balance between recycling and degradation of HER2 determines how much T-DM1 is processed and how effective the conjugate is.
Coupling to signaling and gene expression
In simple terms: Uptake changes what the cell hears and how it responds.
Because endocytosis is context-dependent, positive regulation feeds back into signaling and transcription. CD44-mediated iron endocytosis regulates epigenetic plasticity, linking uptake to chromatin state. Endocytic regulation of TGF-beta signaling shows how uptake controls a major growth factor pathway. These examples demonstrate that positive regulation of endocytosis is not merely a transport event but a mechanism that shapes cell properties.
Key Genes Involved in GO:0045807 positive regulation of endocytosis
The following genes and proteins are established components or regulators of endocytosis and its positive regulation, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RAB5A | Small GTPase that controls early endosome identity and fusion | Central node for positive regulation of endocytosis; effector FERRY links endosomes to mRNA localization |
| FERRY complex (FERRY1/FERRY2) | Rab5 effector complex | Connects early endosomes with mRNA localization, expanding endosome functions |
| CD44 | Cell surface receptor mediating iron endocytosis | Links endocytosis to epigenetic plasticity via iron uptake |
| OPTN | Adaptor regulating transferrin receptor trafficking | Disease-associated mutants alter recycling and degradation |
| TFRC | Transferrin receptor, cargo for iron uptake | Readout for endocytic trafficking and recycling |
| TGFBR1/TGFBR2 | TGF-beta receptors sorted through endosomes | Endocytic regulation controls TGF-beta signaling output |
| HER2 (ERBB2) | Receptor tyrosine kinase and ADC target | Endocytosis determines T-DM1 uptake and efficacy |
| CCN2 (CTGF) | Matricellular protein linked to endocytosis and lipid handling | Regulates smooth muscle cell transdifferentiation in atherosclerosis |
| RAB7 | Late endosome/lysosome trafficking GTPase | Controls degradation arm of endocytic sorting |
| EEA1 | Early endosome antigen, Rab5 effector | Marker and effector of early endosome fusion |
| CLTC | Clathrin heavy chain | Core coat component for vesicle formation |
| AP2M1 | AP-2 adaptor subunit | Cargo selection at the plasma membrane |
| DNM2 | Dynamin GTPase | Membrane scission during vesicle formation |
| PIK3C3 (VPS34) | Phosphatidylinositol 3-kinase | Generates PI3P for endosomal recruitment |
| VPS34 complex components | Endosomal sorting machinery | Supports endosome maturation and sorting |
| RAB11 | Recycling endosome GTPase | Controls receptor recycling back to the surface |
| EPS15 | Endocytic adaptor | Facilitates cargo recruitment and vesicle formation |
| SMAD2/3 | TGF-beta signal transducers | Downstream readout of endocytic regulation of TGF-beta |
How Is positive regulation of endocytosis Regulated?
Positive regulation of endocytosis is itself regulated at multiple levels. Signaling inputs from growth factor receptors and adhesion molecules tune the rate of uptake in a context-dependent manner. Rab5 and its effectors, including FERRY, act as molecular switches that can be upregulated to increase early endosome fusion. Adaptor proteins such as optineurin modulate receptor trafficking, and their disease-associated mutants shift the balance between recycling and degradation. In cancer, therapeutic pressure can select for changes in endocytic flux, as seen when pyrotinib increases drug endocytosis to promote T-DM1 antitumor effects. Iron availability and CD44 expression also feed back on endocytic activity and epigenetic state. Together, these layers allow cells to adjust uptake without permanently altering the core machinery.
positive regulation of endocytosis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HER2 (ERBB2) | HER2-positive breast cancer and ADC response | HER2-positive cell lines with KO or overexpression of endocytic regulators, treated with T-DM1 |
| CCN2 | Atherosclerosis and smooth muscle transdifferentiation | Vascular smooth muscle cell models with CCN2 KO or overexpression |
| OPTN | Neurodegeneration and transferrin receptor trafficking | Neuronal cell lines expressing disease-associated OPTN mutants |
| CD44 | Iron endocytosis and epigenetic plasticity | Cancer cell lines with CD44 KO or overexpression and iron uptake assays |
| TGFBR1/TGFBR2 | TGF-beta signaling and fibrosis/cancer | Epithelial cells with receptor knock-in or KO to track endocytic sorting |
Cancer and antibody-drug conjugate response
In HER2-positive cancer cells, the dynamics of endocytosis and degradation of the antibody-drug conjugate T-DM1 determine how much active drug is released. Positive regulation of endocytosis can therefore be exploited therapeutically: pyrotinib promotes the antitumor effect of T-DM1 by increasing drug endocytosis in HER2-positive breast cancer. These findings place GO:0045807 at the center of efforts to overcome resistance to ADCs.
Atherosclerosis and vascular remodeling
Cellular communication network factor 2 (CCN2) regulates smooth muscle cell transdifferentiation and lipid accumulation in atherosclerosis, a process that involves endocytic handling of lipids and matrix signals. Positive regulation of endocytosis in vascular cells can thus influence plaque biology and smooth muscle phenotype.
Neurodegeneration and trafficking disorders
Optineurin regulates transferrin receptor trafficking, and its disease-associated mutants alter this pathway, linking endocytic regulation to neurodegenerative mechanisms. Because endocytosis controls receptor and nutrient delivery in neurons, perturbations in positive regulation can contribute to neuronal dysfunction.
Metabolic and epigenetic reprogramming
CD44-mediated iron endocytosis regulates epigenetic plasticity, showing that uptake of iron can change chromatin and gene expression programs. This connects positive regulation of endocytosis to metabolic reprogramming in cancer and other diseases.
From positive regulation of endocytosis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene reduce endocytic rate? | CRISPR knockout cell line with fluorescent cargo uptake assay |
| Does a disease-associated mutation alter trafficking? | Point-mutation knock-in of the variant, followed by imaging of receptor recycling |
| Can a tag be used to follow the protein in live cells? | Tagged knock-in of the endogenous locus with a fluorescent or affinity tag |
| Does overexpression increase uptake and drug sensitivity? | Overexpression cell model treated with antibody-drug conjugate |
| Which genes modify endocytosis in a genome-wide manner? | CRISPR library screening with uptake-based selection |
| How does endocytic regulation change transcriptomes? | RNA-seq after perturbation of candidate regulators |
How to Study the positive regulation of endocytosis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescent cargo uptake assay | Rate and extent of endocytosis | Comparing control and perturbed cells |
| Live-cell confocal imaging | Vesicle dynamics and trafficking routes | Tracking receptor recycling versus degradation |
| Endosomal proteomics | Protein composition of endosomes | Identifying effectors such as FERRY |
| RNA-seq | Transcriptional consequences of altered endocytosis | Downstream signaling and epigenetic readouts |
| CRISPR knockout screening | Genes required for endocytic uptake | Genome-wide discovery of positive regulators |
| Antibody-drug conjugate cytotoxicity assay | Drug delivery and cell killing | Testing endocytosis enhancers in HER2-positive cancer |
| Transferrin receptor recycling assay | Recycling versus degradation balance | Studying OPTN mutants |
| Iron uptake and chromatin assays | Metal delivery and epigenetic state | CD44-dependent endocytosis studies |
Live-cell imaging of endocytic flux
Fluorescent cargo such as transferrin or antibody-drug conjugates can be used to measure uptake rate and trafficking in real time. This approach revealed the dynamics of T-DM1 endocytosis and degradation in HER2-positive cells and is standard for studying positive regulation of endocytosis.
Proteomics and interactomics of endosomes
Isolation of endosomal fractions followed by mass spectrometry identifies regulators and effectors. The characterization of the Rab5 effector FERRY and its link to mRNA localization illustrates how proteomic and biochemical approaches define endosomal complexes.
Transcriptomics and epigenetic readouts
RNA-seq and chromatin assays can reveal downstream consequences of altered endocytosis. CD44-mediated iron endocytosis was shown to regulate epigenetic plasticity, requiring combined uptake and epigenomic measurements. TGF-beta signaling readouts are also used to monitor endocytic sorting outcomes.
CRISPR perturbation and functional genomics
Pooled CRISPR screens with endocytosis-dependent selection can identify positive regulators at scale. Such screens complement focused knockout and knock-in studies of individual candidates.
How CRISPR Can Be Used to Study GO:0045807 positive regulation of endocytosis
Knockout
CRISPR knockout of candidate positive regulators is the most direct way to test necessity. Loss of a gene such as RAB5A or an effector component is expected to reduce endocytic rate, and this can be quantified with fluorescent cargo uptake. Knockout of OPTN alters transferrin receptor trafficking, providing a disease-relevant readout.
Point Mutation
Point-mutation knock-in allows study of disease-associated variants without confounding expression changes. For example, optineurin mutants linked to disease can be introduced at the endogenous locus to assess their effect on receptor trafficking. This approach is valuable when a single amino acid change alters endocytic regulation.
Knock-in
Tagged knock-in of endocytic regulators enables live-cell tracking of the endogenous protein. This is useful for following early endosome components and their effectors, such as the FERRY complex, in their native context. Knock-in of reporters can also be used to monitor signaling downstream of endocytosis.
Overexpression
Overexpression of a positive regulator can increase endocytic uptake and sensitize cells to cargo-delivered drugs. This strategy was effectively used when pyrotinib increased drug endocytosis and enhanced T-DM1 efficacy in HER2-positive breast cancer. Overexpression models are also useful for testing sufficiency of a candidate regulator.
How EDITGENE Supports positive regulation of endocytosis Research
Researchers studying positive regulation of endocytosis-related genes often need to determine whether a candidate gene is causally involved in uptake, sorting or downstream signaling, and whether a specific variant alters that function. EDITGENE provides the CRISPR cell models and screening services needed to move from correlation to causation in endocytic biology.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of endocytosis research.
Frequently Asked Questions About positive regulation of endocytosis
What is GO:0045807 positive regulation of endocytosis?
GO:0045807 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of endocytosis, the vesicular uptake of extracellular material and membrane components.
What genes are involved in positive regulation of endocytosis?
Key genes include RAB5A and its effector FERRY, OPTN, CD44, TFRC, HER2 and TGF-beta receptors, all of which have been linked to endocytic regulation in published studies.
How is endocytosis positively regulated?
Positive regulation occurs through signals that increase cargo recognition, vesicle formation, early endosome fusion and sorting, often in a context-dependent manner.
Why is positive regulation of endocytosis important in cancer?
It determines how much drug enters tumor cells; increasing endocytosis of T-DM1 can enhance antitumor activity in HER2-positive breast cancer.
What is the role of Rab5 in endocytosis?
Rab5 controls early endosome identity and fusion, and its effector FERRY links early endosomes to mRNA localization.
How does optineurin affect endocytosis?
Optineurin regulates transferrin receptor trafficking, and its disease-associated mutants alter recycling and degradation.
Can CRISPR be used to study positive regulation of endocytosis?
Yes, knockout, point-mutation knock-in, tagged knock-in and overexpression models are all used to test necessity and sufficiency of endocytic regulators.
What methods measure endocytosis rate?
Fluorescent cargo uptake assays, live-cell imaging, endosomal proteomics and CRISPR screens are commonly used.
How does CD44 relate to endocytosis?
CD44 mediates iron endocytosis, which regulates epigenetic plasticity.
What diseases are linked to endocytic regulation?
Cancer drug response, atherosclerosis, neurodegeneration and metabolic/epigenetic reprogramming have all been linked to positive regulation of endocytosis.
Conclusion
GO:0045807 positive regulation of endocytosis is a central biological process that controls how cells sample their environment, tune receptor signaling and respond to therapeutics. The literature shows that this regulation is context-dependent and mediated by defined molecular players such as Rab5, FERRY, optineurin, CD44 and HER2. Understanding and manipulating these regulators has direct implications for cancer therapy, vascular disease and neurodegeneration. CRISPR-based cell models and functional genomics provide the tools to move this field forward.
References
- 1. Sigismund S et al.. 2021. Endocytosis in the context-dependent regulation of individual and collective cell properties.. Nat Rev Mol Cell Biol 22(9):625-643 PMID: 34075221
- 2. Müller S et al.. 2020. CD44 regulates epigenetic plasticity by mediating iron endocytosis.. Nat Chem 12(10):929-938 PMID: 32747755
- 3. Schuhmacher JS et al.. 2023. The Rab5 effector FERRY links early endosomes with mRNA localization.. Mol Cell 83(11):1839-1855.e13 PMID: 37267905
- 4. Xu Q et al.. 2024. Cellular communication network factor 2 regulates smooth muscle cell transdifferentiation and lipid accumulation in atherosclerosis.. Cardiovasc Res 120(17):2191-2207 PMID: 39365752
- 5. Liang K et al.. 2021. Dynamics of Endocytosis and Degradation of Antibody-Drug Conjugate T-DM1 in HER2 Positive Cancer Cells.. Drug Des Devel Ther 15:5135-5150 PMID: 34992350
- 6. Ren W et al.. 2025. Pyrotinib promotes the antitumor effect of T-DM1 by increasing drug endocytosis in HER2-positive breast cancer.. Sci Rep 15(1):18625 PMID: 40437017
- 7. Chen YG. 2009. Endocytic regulation of TGF-beta signaling.. Cell Res 19(1):58-70 PMID: 19050695
- 8. Moharir SC et al.. 2023. Regulation of transferrin receptor trafficking by optineurin and its disease-associated mutants.. Prog Mol Biol Transl Sci 194:67-78 PMID: 36631201
